• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用不同勾画指南定义肛门癌临床靶体积时,危险器官的剂量学比较。

Dosimetric comparison of organs at risk using different contouring guidelines for definition of the clinical target volume in anal cancer.

机构信息

Department of Radiation Oncology, Klinikum rechts der Isar, TU München, Ismaninger Str. 22, 81675, Munich, Germany.

Partner Site Munich, Deutsches Konsortium für Translationale Krebsforschung (DKTK), Munich, Germany.

出版信息

Strahlenther Onkol. 2020 Apr;196(4):368-375. doi: 10.1007/s00066-020-01587-y. Epub 2020 Feb 3.

DOI:10.1007/s00066-020-01587-y
PMID:32016496
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7089901/
Abstract

BACKGROUND

There are different contouring guidelines for definition of the clinical target volume (CTV) for intensity-modulated radiation therapy (IMRT) of anal cancer (AC). We conducted a planning comparison study to evaluate and compare the dose to relevant organs at risk (OARs) while using different CTV definitions.

METHODS

Twelve patients with a primary diagnosis of anal cancer, who were treated with primary chemoradiation (CRT), were selected. We generated four guideline-specific CTVs and subsequently planned target volumes (PTVs) on the planning CT scan of each patient. An IMRT plan for volumetric arc therapy (VMAT) was set up for each PTV. Dose parameters of the planned target volume (PTV) and OARs were evaluated and compared, too.

RESULTS

The mean volume of the four PTVs ranged from 2138 cc to 2433 cc. The target volumes contoured by the authors based on the recommendations of each group were similar in the pelvis, while they differed significantly in the inguinal region. There were no significant differences between the four target volumes with regard to the dose parameters of the cranially located OARs. Conversely, some dose parameters concerning the genitals and the skin varied significantly among the different guidelines.

CONCLUSION

The four contouring guidelines differ significantly concerning the inguinal region. In order to avoid inguinal recurrence and to protect relevant OARs, further investigations are needed to generate uniform standards for definition of the elective clinical target volume in the inguinal region.

摘要

背景

针对肛门癌(AC)调强放疗(IMRT)的临床靶区(CTV)定义,存在不同的勾画指南。我们进行了一项计划比较研究,以评估和比较使用不同CTV 定义时相关危及器官(OAR)的剂量。

方法

选择了 12 名经病理证实为原发性肛门癌、接受同步放化疗(CRT)的患者。我们为每位患者的计划 CT 扫描生成了四个指南特异性 CTV,并随后规划了靶区(PTV)。为每个 PTV 设立了容积旋转调强放疗(VMAT)的 IMRT 计划。评估和比较了计划靶区(PTV)和 OAR 的剂量参数。

结果

四个 PTV 的平均体积范围为 2138cc 至 2433cc。根据每组建议勾画的作者的靶区在骨盆内相似,但在腹股沟区域差异显著。对于颅顶 OAR 的剂量参数,四个靶区之间没有显著差异。相反,不同指南之间关于生殖器和皮肤的一些剂量参数存在显著差异。

结论

四个勾画指南在腹股沟区域有显著差异。为了避免腹股沟复发和保护相关 OAR,需要进一步研究,为腹股沟区域的选择性临床靶区定义生成统一标准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a64/7089901/cb781aefc350/66_2020_1587_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a64/7089901/85e273154848/66_2020_1587_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a64/7089901/2790cf00bc09/66_2020_1587_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a64/7089901/cb781aefc350/66_2020_1587_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a64/7089901/85e273154848/66_2020_1587_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a64/7089901/2790cf00bc09/66_2020_1587_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a64/7089901/cb781aefc350/66_2020_1587_Fig3_HTML.jpg

相似文献

1
Dosimetric comparison of organs at risk using different contouring guidelines for definition of the clinical target volume in anal cancer.使用不同勾画指南定义肛门癌临床靶体积时,危险器官的剂量学比较。
Strahlenther Onkol. 2020 Apr;196(4):368-375. doi: 10.1007/s00066-020-01587-y. Epub 2020 Feb 3.
2
Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer.澳大利亚胃肠肿瘤研究组(AGITG)针对肛门癌调强放疗的勾画图谱和规划指南。
Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1455-62. doi: 10.1016/j.ijrobp.2011.12.058. Epub 2012 Mar 6.
3
Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines.我们是否已经为肛门癌的靶区定义提出了足够的建议?在既定勾画指南的背景下,基于 PET 成像的失败模式分析。
BMC Cancer. 2019 Jul 29;19(1):742. doi: 10.1186/s12885-019-5970-0.
4
Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes.通过适形避让调强放射治疗对肛管癌进行器官保留:骨盆及腹股沟/股淋巴结覆盖范围的剂量学评估
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):274-81. doi: 10.1016/j.ijrobp.2005.05.052.
5
Dosimetric quantification of the incidental irradiation of the 'true' (deep) ano-inguinal lymphatic drainage of anal cancer patients not described in conventional contouring guidelines.常规勾画指南中未描述的肛门癌患者“真实”(深部)肛旁淋巴结引流的偶然照射的剂量学定量。
Acta Oncol. 2018 Jun;57(6):825-830. doi: 10.1080/0284186X.2017.1415459. Epub 2018 Jan 3.
6
Helical tomotherapy for the treatment of anal canal cancer: a dosimetric comparison with 3D conformal radiotherapy.螺旋断层放射治疗肛管癌:与三维适形放疗的剂量学比较
Tumori. 2015 May-Jun;101(3):268-72. doi: 10.5301/tj.5000269. Epub 2015 Apr 16.
7
Dosimetric comparison of different radiation techniques (IMRT vs. 3-dimensional) of the "true" (deep) ano-inguinal lymphatic drainage of anal cancer patients.不同放射治疗技术(调强放疗与三维适形放疗)对肛门癌患者“真正”(深部)会阴腹股沟淋巴结引流区的剂量学比较。
Radiat Oncol. 2018 Nov 22;13(1):227. doi: 10.1186/s13014-018-1174-z.
8
Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.评估蒙特卡罗算法在接受立体定向体部放射治疗的周围型肺癌患者中符合 RTOG 0915 剂量学标准的应用。
J Appl Clin Med Phys. 2016 May 8;17(3):277-293. doi: 10.1120/jacmp.v17i3.6077.
9
Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.肛管直肠癌适形治疗的选择性临床靶区:放射肿瘤学组共识专家组勾画图谱
Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):824-30. doi: 10.1016/j.ijrobp.2008.08.070. Epub 2008 Dec 29.
10
Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.前列腺癌术后放疗:四项共识指南比较及 3D-CRT 与 Tomotherapy-IMRT 的剂量学评估。
Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):725-32. doi: 10.1016/j.ijrobp.2011.12.081. Epub 2012 Mar 22.

引用本文的文献

1
A Systematic Review of Contouring Guidelines in Radiation Oncology: Analysis of Frequency, Methodology, and Delivery of Consensus Recommendations.系统评价放射肿瘤学中的勾画指南:共识推荐的频率、方法学和实施情况分析。
Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):827-835. doi: 10.1016/j.ijrobp.2020.04.011. Epub 2020 Apr 18.

本文引用的文献

1
Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines.我们是否已经为肛门癌的靶区定义提出了足够的建议?在既定勾画指南的背景下,基于 PET 成像的失败模式分析。
BMC Cancer. 2019 Jul 29;19(1):742. doi: 10.1186/s12885-019-5970-0.
2
Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.肛门癌临床实践指南 2018 年版 NCCN 肿瘤学
J Natl Compr Canc Netw. 2018 Jul;16(7):852-871. doi: 10.6004/jnccn.2018.0060.
3
Dosimetric quantification of the incidental irradiation of the 'true' (deep) ano-inguinal lymphatic drainage of anal cancer patients not described in conventional contouring guidelines.
常规勾画指南中未描述的肛门癌患者“真实”(深部)肛旁淋巴结引流的偶然照射的剂量学定量。
Acta Oncol. 2018 Jun;57(6):825-830. doi: 10.1080/0284186X.2017.1415459. Epub 2018 Jan 3.
4
Quantitative FDG-PET/CT predicts local recurrence and survival for squamous cell carcinoma of the anus.定量氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)可预测肛门鳞状细胞癌的局部复发和生存情况。
Adv Radiat Oncol. 2017 Apr 29;2(3):281-287. doi: 10.1016/j.adro.2017.04.007. eCollection 2017 Jul-Sep.
5
Clinical outcome in patients treated with simultaneous integrated boost - intensity modulated radiation therapy (SIB-IMRT) with and without concurrent chemotherapy for squamous cell carcinoma of the anal canal.肛管鳞状细胞癌患者接受同步整合加量调强放射治疗(SIB-IMRT)联合或不联合同步化疗的临床结局。
Acta Oncol. 2016 Jun;55(6):760-6. doi: 10.3109/0284186X.2015.1124141. Epub 2016 Feb 15.
6
Proposed genitalia contouring guidelines in anal cancer intensity-modulated radiotherapy.肛管癌调强放射治疗中拟议的生殖器轮廓勾画指南。
Br J Radiol. 2015 Jul;88(1051):20150032. doi: 10.1259/bjr.20150032. Epub 2015 May 8.
7
Late effects and quality of life after chemo-radiation for the treatment of anal cancer.肛管癌放化疗后的远期效应及生活质量
Eur J Oncol Nurs. 2015 Oct;19(5):479-85. doi: 10.1016/j.ejon.2015.02.007. Epub 2015 Apr 22.
8
Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial.肢体肉瘤患者采用影像引导放射治疗缩小靶区后晚期毒性显著降低:放射肿瘤学组RTOG-0630试验结果
J Clin Oncol. 2015 Jul 10;33(20):2231-8. doi: 10.1200/JCO.2014.58.5828. Epub 2015 Feb 9.
9
Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal canal cancer.肛管癌根治性放化疗后与阴道狭窄相关的临床和治疗因素。
Pract Radiat Oncol. 2015 May-Jun;5(3):e113-e118. doi: 10.1016/j.prro.2014.09.003. Epub 2014 Oct 30.
10
Intensity-modulated Radiation Therapy for Anal Cancer: Results From a Multi-Institutional Retrospective Cohort Study.肛管癌的调强放射治疗:一项多机构回顾性队列研究的结果
Am J Clin Oncol. 2016 Feb;39(1):8-12. doi: 10.1097/COC.0000000000000009.